Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy & Safety of SmofKabiven Peripheral vs Compounded Emulsion: A Randomized, Active-Controlled, Open-Labelled, Multi-Centre Study in Adult Surgical Patients Requiring Parenteral Nutrition

NCT03792087 is registered in ClinicalTrials.gov with Fresenius Kabi as lead sponsor.

NCT NCT03792087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03792087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy & Safety of SmofKabiven Peripheral vs Compounded Emulsion: A Randomized, Active-Controlled, Open-Labelled, Multi-Centre Study in Adult Surgical Patients Requiring Parenteral Nutrition
Lead sponsor
Fresenius Kabi
Phase
Phase 3
Overall status
Completed
Start date
December 21, 2017
Completion date
December 30, 2018
Enrollment
272 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

parenteral feeding, surgery